Amarantus Bioscience Holdings Inc (AMBS)

[myersvodka]

End of 2014 alone – will put us in that position.

Come on put the whole thing in there.

With that being said, we recognize that it is not optimal to up list from a position of weakness, and therefore we will only consider an up list from a position of strength while the Company is making good progress in the market. We believe the milestones we’ve outlined above – for the end of 2014 alone – will put us in that position. However, if we do not believe we have achieved sufficient shareholder value creation, we will consider delaying the up list until such time as the market recognizes our true value. - See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/fundamental-milestones-ahead-listing-strength/#sthash.298VSDYB.dpuf